Ayalon Insurance Comp Ltd. Gilead Sciences, Inc. Transaction History

Ayalon Insurance Comp Ltd.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 13, 2021	SELL	$67.69 - $73.03 $213,223 - $230,044	-3,150 Closed	0 $0
Q1 2021 Apr 28, 2021	BUY	$60.0 - $68.46 $189,000 - $215,648	3,150 New	3,150 $209,000
Q2 2020 Jul 07, 2020	SELL	$72.34 - $84.0 $54,616 - $63,420	-755 Closed	0 $0
Q2 2018 Aug 08, 2018	BUY	$64.88 - $75.68 $48,984 - $57,138	755 New	755 $53,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Ayalon Insurance Comp Ltd., based on Form 13F filings with the SEC.

Stay updated on Ayalon Insurance Comp Ltd. with notifications on news.